TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
IDL Biotech AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 34,807 | 22,330 | 22,783 |
Financial expenses | 6 | 2 | 32 |
Earnings before taxes | 236 | -12,421 | -12,795 |
EBITDA | 3,108 | -12,002 | -10,326 |
Total assets | 38,064 | 40,290 | 39,652 |
Current assets | 31,295 | 34,313 | 25,376 |
Current liabilities | 9,243 | 5,945 | 8,901 |
Equity capital | 28,734 | 34,257 | 26,535 |
- share capital | 23,860 | 24,599 | 26,425 |
Employees (average) | 20 | 16 | 18 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 75.5% | 85.0% | 66.9% |
Turnover per employee | 1,740 | 1,396 | 1,266 |
Profit as a percentage of turnover | 0.7% | -55.6% | -56.2% |
Return on assets (ROA) | 0.6% | -30.8% | -32.2% |
Current ratio | 338.6% | 577.2% | 285.1% |
Return on equity (ROE) | 0.8% | -36.3% | -48.2% |
Change turnover | 13,148 | 1,121 | -6,914 |
Change turnover % | 61% | -23% | |
Chg. No. of employees | 4 | -2 | 0 |
Chg. No. of employees % | 25% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.